Advertisement

Index by author

February 01, 2004; Volume 65,Issue 2

  1. Adams, B. A.

    1. Differential Modulation of CaV2.3 Ca2+ Channels by Gαq/11-Coupled Muscarinic Receptors
      R. A. Bannister, K. Melliti and B. A. Adams
      Molecular Pharmacology February 2004, 65 (2) 381-388; DOI: https://doi.org/10.1124/mol.65.2.381

  2. Adegboyega, Patrick A.

    1. Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts
      Randy C. Mifflin, Jamal I. Saada, John F. Di Mari, John D. Valentich, Patrick A. Adegboyega and Don W. Powell
      Molecular Pharmacology February 2004, 65 (2) 470-478; DOI: https://doi.org/10.1124/mol.65.2.470

  3. Backlund, Maria

    1. Different Structural Requirements of the Ligand Binding Domain of the Aryl Hydrocarbon Receptor for High- and Low-Affinity Ligand Binding and Receptor Activation
      Maria Backlund and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 2004, 65 (2) 416-425; DOI: https://doi.org/10.1124/mol.65.2.416

  4. Baker, Elizabeth R.

    1. Pharmacological Properties of α9α10 Nicotinic Acetylcholine Receptors Revealed by Heterologous Expression of Subunit Chimeras
      Elizabeth R. Baker, Ruud Zwart, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology February 2004, 65 (2) 453-460; DOI: https://doi.org/10.1124/mol.65.2.453

  5. Bannister, R. A.

    1. Differential Modulation of CaV2.3 Ca2+ Channels by Gαq/11-Coupled Muscarinic Receptors
      R. A. Bannister, K. Melliti and B. A. Adams
      Molecular Pharmacology February 2004, 65 (2) 381-388; DOI: https://doi.org/10.1124/mol.65.2.381

  6. Bayer, Barbara

    1. Systemic Morphine Administration Suppresses Genes Involved in Antigen Presentation
      Karen Beagles, Anton Wellstein and Barbara Bayer
      Molecular Pharmacology February 2004, 65 (2) 437-442; DOI: https://doi.org/10.1124/mol.65.2.437

  7. Beagles, Karen

    1. Systemic Morphine Administration Suppresses Genes Involved in Antigen Presentation
      Karen Beagles, Anton Wellstein and Barbara Bayer
      Molecular Pharmacology February 2004, 65 (2) 437-442; DOI: https://doi.org/10.1124/mol.65.2.437

  8. Becker, Bryan N.

    1. The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties
      Bryan N. Becker, Hui-fang Cheng, Timothy G. Hammond and Raymond C. Harris
      Molecular Pharmacology February 2004, 65 (2) 362-369; DOI: https://doi.org/10.1124/mol.65.2.362

  9. Blumberg, Peter M.

    1. Design of a High-Affinity Competitive Antagonist of the Vanilloid Receptor Selective for the Calcium Entry-Linked Receptor Population
      Attila Tóth, Peter M. Blumberg, Zili Chen and Alan P. Kozikowski
      Molecular Pharmacology February 2004, 65 (2) 282-291; DOI: https://doi.org/10.1124/mol.65.2.282

  10. Bright, Damian P.

    1. Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane
      Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
      Molecular Pharmacology February 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443
« Previous (Pages : 1 2 3 4 5 6 ... 13) Next »
Back to top

In this issue

Advertisement